88 related articles for article (PubMed ID: 2031995)
21. Statistical evaluation of mathematical models for microbial growth.
López S; Prieto M; Dijkstra J; Dhanoa MS; France J
Int J Food Microbiol; 2004 Nov; 96(3):289-300. PubMed ID: 15454319
[TBL] [Abstract][Full Text] [Related]
22. A mutual information criterion with applications to canonical correlation analysis and graphical models.
DelSole T; Tippett MK
Stat (Int Stat Inst); 2021 Dec; 10(1):e385. PubMed ID: 34691453
[TBL] [Abstract][Full Text] [Related]
23. Fit fluctuating blood drug concentration: a beginner's first note.
Wu G
Pharmacol Res; 1996 Jun; 33(6):379-83. PubMed ID: 8971962
[TBL] [Abstract][Full Text] [Related]
24. Enzyme kinetic modelling as a tool to analyse the behaviour of cytochrome P450 catalysed reactions: application to amitriptyline N-demethylation.
Schmider J; Greenblatt DJ; Harmatz JS; Shader RI
Br J Clin Pharmacol; 1996 Jun; 41(6):593-604. PubMed ID: 8799527
[TBL] [Abstract][Full Text] [Related]
25. The mathematics behind modeling.
Rosenblatt J
Adv Exp Med Biol; 1998; 445():115-29. PubMed ID: 9781385
[TBL] [Abstract][Full Text] [Related]
26. Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test.
Glatting G; Kletting P; Reske SN; Hohl K; Ring C
Med Phys; 2007 Nov; 34(11):4285-92. PubMed ID: 18072493
[TBL] [Abstract][Full Text] [Related]
27. Modelling conjugation with stochastic differential equations.
Philipsen KR; Christiansen LE; Hasman H; Madsen H
J Theor Biol; 2010 Mar; 263(1):134-42. PubMed ID: 19941872
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous optimization of limited sampling points for pharmacokinetic analysis of amrubicin and amrubicinol in cancer patients.
Makino Y; Watanabe M; Makihara RA; Nokihara H; Yamamoto N; Ohe Y; Sugiyama E; Sato H; Hayashi Y
Asia Pac J Clin Oncol; 2016 Sep; 12(3):259-64. PubMed ID: 26948073
[TBL] [Abstract][Full Text] [Related]
29. Bayesian information criterion for longitudinal and clustered data.
Jones RH
Stat Med; 2011 Nov; 30(25):3050-6. PubMed ID: 21805487
[TBL] [Abstract][Full Text] [Related]
30. Comparison of 5-fluorouracil pharmacokinetics in whole blood, plasma, and red blood cells in patients with colorectal cancer.
Wattanatorn W; McLeod HL; Macklon F; Reid M; Kendle KE; Cassidy J
Pharmacotherapy; 1997; 17(5):881-6. PubMed ID: 9324177
[TBL] [Abstract][Full Text] [Related]
31. Drug disposition viewed in terms of the fractal volume of distribution.
Karalis V; Macheras P
Pharm Res; 2002 May; 19(5):696-703. PubMed ID: 12069175
[TBL] [Abstract][Full Text] [Related]
32. Genetic parameters for various random regression models to describe the weight data of pigs.
Huisman AE; Veerkamp RF; van Arendonk JA
J Anim Sci; 2002 Mar; 80(3):575-82. PubMed ID: 11892676
[TBL] [Abstract][Full Text] [Related]
33. Selection of the order of autoregressive models for spectral analysis of Doppler ultrasound signals.
Schlindwein FS; Evans DH
Ultrasound Med Biol; 1990; 16(1):81-91. PubMed ID: 2181765
[TBL] [Abstract][Full Text] [Related]
34. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.
Yamaoka K; Nakagawa T; Uno T
J Pharmacokinet Biopharm; 1978 Apr; 6(2):165-75. PubMed ID: 671222
[No Abstract] [Full Text] [Related]
35. Investigation on the improvement of prediction by bootstrap model averaging.
Holländer N; Augustin NH; Sauerbrei W
Methods Inf Med; 2006; 45(1):44-50. PubMed ID: 16482369
[TBL] [Abstract][Full Text] [Related]
36. Motion estimation using Statistical Learning Theory.
Wechsler H; Duric Z; Li F; Cherkassky V
IEEE Trans Pattern Anal Mach Intell; 2004 Apr; 26(4):466-78. PubMed ID: 15382651
[TBL] [Abstract][Full Text] [Related]
37. Experimental design and efficient parameter estimation in population pharmacokinetics.
al-Banna MK; Kelman AW; Whiting B
J Pharmacokinet Biopharm; 1990 Aug; 18(4):347-60. PubMed ID: 2231324
[TBL] [Abstract][Full Text] [Related]
38. Optimal selection of metabolic fluxes for in vivo measurement. I. Development of mathematical methods.
Savinell JM; Palsson BO
J Theor Biol; 1992 Mar; 155(2):201-14. PubMed ID: 1453697
[TBL] [Abstract][Full Text] [Related]
39. Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.
Panhard X; Mentré F
Stat Med; 2005 May; 24(10):1509-24. PubMed ID: 15761916
[TBL] [Abstract][Full Text] [Related]
40. Application of mean residence-time concepts to pharmacokinetic systems with noninstantaneous input and nonlinear elimination.
Cheng HY; Jusko WJ
Pharm Res; 1989 Jan; 6(1):4-12. PubMed ID: 2717515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
